Stifel Financial’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-9,839
| Closed | -$287K | – | 3406 |
|
|
2024
Q3 | $287K | Sell |
9,839
-3,008
| -23% | -$87.6K | ﹤0.01% | 2987 |
|
|
2024
Q2 | $298K | Sell |
12,847
-26
| -0.2% | -$604 | ﹤0.01% | 2919 |
|
|
2024
Q1 | $264K | Sell |
12,873
-22
| -0.2% | -$451 | ﹤0.01% | 2977 |
|
|
2023
Q4 | $277K | Buy |
12,895
+541
| +4% | +$11.6K | ﹤0.01% | 2894 |
|
|
2023
Q3 | $255K | Sell |
12,354
-905
| -7% | -$18.7K | ﹤0.01% | 2873 |
|
|
2023
Q2 | $391K | Sell |
13,259
-268
| -2% | -$7.91K | ﹤0.01% | 2674 |
|
|
2023
Q1 | $312K | Buy |
13,527
+120
| +0.9% | +$2.77K | ﹤0.01% | 2789 |
|
|
2022
Q4 | $373K | Sell |
13,407
-141
| -1% | -$3.92K | ﹤0.01% | 2636 |
|
|
2022
Q3 | $415K | Buy |
13,548
+558
| +4% | +$17.1K | ﹤0.01% | 2548 |
|
|
2022
Q2 | $383K | Sell |
12,990
-650
| -5% | -$19.2K | ﹤0.01% | 2618 |
|
|
2022
Q1 | $439K | Sell |
13,640
-15
| -0.1% | -$483 | ﹤0.01% | 2646 |
|
|
2021
Q4 | $609K | Sell |
13,655
-1,012
| -7% | -$45.1K | ﹤0.01% | 2482 |
|
|
2021
Q3 | $740K | Buy |
14,667
+1,617
| +12% | +$81.6K | ﹤0.01% | 2314 |
|
|
2021
Q2 | $1.02M | Buy |
13,050
+84
| +0.6% | +$6.59K | ﹤0.01% | 2077 |
|
|
2021
Q1 | $740K | Buy |
12,966
+6,955
| +116% | +$397K | ﹤0.01% | 2201 |
|
|
2020
Q4 | $503K | Sell |
6,011
-260
| -4% | -$21.8K | ﹤0.01% | 2312 |
|
|
2020
Q3 | $225K | Buy |
+6,271
| New | +$225K | ﹤0.01% | 2558 |
|
|
2020
Q2 | – | Sell |
-13,621
| Closed | -$236K | – | 2871 |
|
|
2020
Q1 | $236K | Buy |
13,621
+1,726
| +15% | +$29.9K | ﹤0.01% | 2344 |
|
|
2019
Q4 | $207K | Buy |
11,895
+320
| +3% | +$5.57K | ﹤0.01% | 2747 |
|
|
2019
Q3 | $178K | Hold |
11,575
| – | – | ﹤0.01% | 2677 |
|
|
2019
Q2 | $240K | Buy |
+11,575
| New | +$240K | ﹤0.01% | 2622 |
|